一、今日公告速览格林达(603931)公告其持股5%以上股东宁波聚合股权投资合伙企业(有限合伙)近期通过集中竞价交易方式减持公司股份,减持比例达到公司总股本的1%。本次减持完成后,宁波聚合持股比例由19%下降至18%。公司认为本次减持属于股东正常行为,不会对公司治理结构及持续经营产生重大影响。康希诺(688185)宣布其研发的脊髓灰质炎疫苗(Vero细胞)已获得国家药品监督管理局的临床试验批准...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.